cidrap.umn5 天
Procalcitonin doesn't reduce IV antibiotic duration in kids, trial finds
The trial, conducted in the United Kingdom, found that a procalcitonin-guided algorithm didn't reduce IV antibiotic duration ...
cidrap.umn5 天
Study examines C diff recurrence, risk factors in cancer patients
Among 547 episodes of C difficile infection documented in cancer patients in Australia and Spain, 50% were severe, and the 90 ...
Immuron Partners With Monash University To Combat Antimicrobial Resistance
Immuron Limited (IMRN), an Australian-based biopharmaceutical company, Wednesday, announced a new research collaboration with Monash ...
Immuron Announces New Research Collaboration targeting Antimicrobial Resistance
Highlights: New Research Collaboration with Monash University One proposal will target Antimicrobial Resistant Pathways to develop broad spectrum therapeutic drug productsSecond project proposal will ...